Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELE AMUNDSON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1578882981
CMS profile
11077302
Location
TEANECK, NJ

General Payments · PY2021–2024

$691.48

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$495.25

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $495.25 18

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $14.06 1
PY2022 $36.95 1
PY2023 $145.22 3
PY2024 $495.25 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.85 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106437537 CMS
AstraZeneca Pharmaceuticals LP $16.02 03/15/2024 Food and Beverage Undisputed 01/23/2026 1105761090 CMS
AstraZeneca Pharmaceuticals LP $16.21 04/26/2024 Food and Beverage Undisputed 01/23/2026 1105212624 CMS
AstraZeneca Pharmaceuticals LP $16.64 06/08/2024 Food and Beverage Undisputed 01/23/2026 1104741607 CMS
AstraZeneca Pharmaceuticals LP $16.14 08/02/2024 Food and Beverage Undisputed 01/23/2026 1104658049 CMS
AstraZeneca Pharmaceuticals LP $15.95 09/24/2024 Food and Beverage Undisputed 01/23/2026 1104337994 CMS
AstraZeneca Pharmaceuticals LP $16.41 11/22/2024 Food and Beverage Undisputed 01/23/2026 1104466766 CMS
Cumberland Pharmaceuticals, Inc. $13.39 06/12/2024 Food and Beverage Undisputed 01/23/2026 1146404592 CMS
Eisai Inc. $13.08 02/08/2024 Food and Beverage Undisputed 01/23/2026 1110815482 CMS
Eisai Inc. $18.53 04/15/2024 Food and Beverage Undisputed 01/23/2026 1110815478 CMS
Eisai Inc. $21.46 07/18/2024 Food and Beverage Undisputed 01/23/2026 1110815480 CMS
Eisai Inc. $50.00 09/29/2024 Food and Beverage Undisputed 01/23/2026 1110815484 CMS
Genmab U.S., Inc. $113.71 05/07/2024 Food and Beverage Undisputed 01/23/2026 1126838204 CMS
GlaxoSmithKline, LLC. $21.33 08/13/2024 Food and Beverage Undisputed 01/23/2026 1116416884 CMS
GlaxoSmithKline, LLC. $81.31 09/27/2024 Food and Beverage Undisputed 01/23/2026 1116584441 CMS
Merck Sharp & Dohme LLC $17.98 02/22/2024 Food and Beverage Undisputed 01/23/2026 1141750593 CMS
Merck Sharp & Dohme LLC $16.27 10/04/2024 Food and Beverage Undisputed 01/23/2026 1141750785 CMS
Myriad Genetic Laboratories, Inc. $16.97 08/12/2024 Food and Beverage Undisputed 01/23/2026 1152543481 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.